Cargando…
Levels of S100B are raised in female patients with schizophrenia
BACKGROUND: The neurotrophic factor, S100B, is released primarily from astrocytes, with serum and CSF levels of S100B reported as altered in schizophrenia. However, many of these reports are contradictory. Here, serum levels of S100B in schizophrenia and influence of age, gender, medication and illn...
Autores principales: | O’Connell, Kara, Thakore, Jogin, Dev, Kumlesh K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3664595/ https://www.ncbi.nlm.nih.gov/pubmed/23705829 http://dx.doi.org/10.1186/1471-244X-13-146 |
Ejemplares similares
-
Inhibition of the Interaction Between Group I Metabotropic Glutamate Receptors and PDZ-Domain Proteins Prevents Hippocampal Long-Term Depression, but Not Long-Term Potentiation
por: Neyman, Sergey, et al.
Publicado: (2019) -
The chemokine fractalkine (CX3CL1) attenuates H(2)O(2)-induced demyelination in cerebellar slices
por: O’Sullivan, Sinead A., et al.
Publicado: (2017) -
Systematic Review and Meta-Analysis of Circulating S100B Blood Levels in Schizophrenia
por: Aleksovska, Katina, et al.
Publicado: (2014) -
RNA interference as a therapeutic strategy for treating CNS disorders
por: Hoyer, Daniel, et al.
Publicado: (2006) -
The Effects of Antipsychotics in Experimental Models of Krabbe Disease
por: Sharma, Kapil, et al.
Publicado: (2023)